Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Revolution Medicines (RVMD) Shares Outstanding (2018 - 2025)

Revolution Medicines (RVMD) has 7 years of Shares Outstanding data on record, last reported at $197.0 million in Q4 2025.

  • For Q4 2025, Shares Outstanding rose 5.97% year-over-year to $197.0 million; the TTM value through Dec 2025 reached $197.0 million, up 5.97%, while the annual FY2025 figure was $197.0 million, 5.97% up from the prior year.
  • Shares Outstanding reached $197.0 million in Q4 2025 per RVMD's latest filing, up from $189.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $197.0 million in Q4 2025 and bottomed at $73.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $127.8 million, with a median of $109.3 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: rose 1.08% in 2022, then soared 82.14% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $74.1 million in 2021, then rose by 21.94% to $90.4 million in 2022, then skyrocketed by 82.14% to $164.7 million in 2023, then grew by 12.89% to $185.9 million in 2024, then increased by 5.97% to $197.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $197.0 million in Q4 2025, $189.7 million in Q3 2025, and $186.9 million in Q2 2025.